Behavioral cardiology --has its time finally arrived?

Thomas Pickering1, Lynn Clemow, Karina Davidson

  • 1Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.

Insights

Behavioral cardiology reveals heart disease stems from lifestyle and stress, not just genetics. Behavioral treatments can modify these factors, though patient compliance and healthcare system barriers exist.

Area of Science:

  • Cardiology
  • Behavioral Science
  • Public Health

Background:

  • Traditional cardiology focuses on mechanistic causes of heart disease.
  • Behavioral cardiology proposes that lifestyle and psychosocial factors significantly contribute to cardiovascular disease development.
  • Unhealthy lifestyles (smoking, overeating, inactivity) and psychosocial stressors (anxiety, anger, social isolation) are key risk factors.

Purpose of the Study:

  • To highlight the shift from a mechanistic to a broader, behavioral approach in understanding heart disease.
  • To emphasize the role of lifestyle and psychosocial factors in cardiovascular disease and obesity.
  • To introduce behavioral treatment as a method to alter these risk factors.

Main Methods:

  • Review of traditional and behavioral cardiology approaches.
  • Identification of lifestyle factors (physical inactivity, caloric intake) contributing to obesity and diabetes.
  • Analysis of psychosocial stressors implicated in cardiovascular disease (occupational stress, hostility, anger, Type A behavior).

Main Results:

  • Heart disease is largely preventable through modification of lifestyle and psychosocial factors.
  • Obesity and diabetes prevalence are increasing due to inactivity and overeating, potentially reversing declines in cardiovascular deaths.
  • Psychosocial stressors significantly impact cardiovascular health.

Conclusions:

  • Behavioral cardiology offers a comprehensive view of heart disease etiology.
  • Behavioral treatments, involving patient-practitioner collaboration, can modify risk factors.
  • Barriers to effective behavioral treatment include patient non-compliance, provider skill deficits, and systemic healthcare issues like reimbursement.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...